Bottom line
EFAX vs IDEV: the short answer
EFAX (State Street(R) SPDR(R) MSCI EAFE Fossil Fuel Reserves Free ETF) and IDEV (iShares Core MSCI International Developed Markets ETF) share a meaningful slice of their top holdings — about 71% by weight.
But IDEV is far broader, holding 2,337 positions to 647 for EFAX, so beyond the top names it adds exposure EFAX doesn't have.
IDEV is cheaper at 0.04% vs 0.2% — a difference of $16 a year per $10,000 invested.
Over five years, EFAX returned +8.4% a year vs +5.0% for IDEV (reporting dates differ).
Updated Nov 19, 2026
EFAX vs IDEV side by side
| EFAX | IDEV | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | SPDR (State Street) | iShares |
| Category | International Stock | International Stock |
| Expense ratio | 0.2% | 0.04% |
| Annual cost per $10k | $20 | $4 |
| 10-yr cost on $10k (prospectus) | $255 | $51 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +30.9% | +4.5% |
| 5-yr return (annualized) | +8.4% | +5.0% |
| 10-yr return (annualized) | — | — |
| Best quarter | +16.8% | +16.9% |
| Worst quarter | −22.1% | −24.0% |
| Net assets (fund) | $502.7M | $31.6B |
| Number of holdings | 647 | 2,337 |
| Portfolio turnover | 4% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | EFAX | IDEV | Difference |
|---|---|---|---|
| 2024 | +5.1% | +4.5% | +0.6% |
| 2023 | +18.2% | +17.3% | +0.9% |
| 2022 | −16.9% | −14.9% | −1.9% |
| 2021 | +10.7% | +12.7% | −2.0% |
| 2020 | +9.5% | +8.4% | +1.1% |
| 2019 | +22.9% | +23.4% | −0.5% |
| 2018 | −14.4% | −14.3% | −0.1% |
Source: Fund prospectus bar charts
Holdings overlap
16 of EFAX's top 25 holdings also appear in IDEV's top 25.
| Holding | EFAX | IDEV |
|---|---|---|
| ASML Holding NV | 3.80% | 2.19% |
| HSBC Holdings PLC | 1.62% | 1.24% |
| Roche Holding AG | 1.44% | 1.05% |
| Novartis AG | 1.43% | 0.98% |
| AstraZeneca PLC | 1.41% | 0.88% |
| Nestle SA | 1.32% | 0.88% |
| Mitsubishi UFJ Financial Group Inc | 1.05% | 0.82% |
| Banco Santander SA | 0.98% | 0.70% |
| Commonwealth Bank of Australia | 0.95% | 0.72% |
| Allianz SE | 0.89% | 0.65% |
| Schneider Electric SE | 0.89% | 0.63% |
| ABB Ltd | 0.85% | 0.53% |
| Rolls-Royce Holdings PLC | 0.80% | 0.57% |
| Sap Se | 0.79% | 0.65% |
| UBS Group AG | 0.78% | 0.57% |
Source: SEC Form N-PORT
EFAX top 10
- ASML Holding NV — 3.80%
- State Street Global Advisors — 2.02%
- HSBC Holdings PLC — 1.62%
- Roche Holding AG — 1.44%
- Novartis AG — 1.43%
- AstraZeneca PLC — 1.41%
- Nestle SA — 1.32%
- Siemens AG — 1.19%
- Tokyo Electron Ltd — 1.06%
- Mitsubishi UFJ Financial Group Inc — 1.05%
IDEV top 10
- ASML Holding N.V. — 2.19%
- Hsbc Holdings Plc — 1.24%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.16%
- Roche Holding AG — 1.05%
- Royal Bank Of Canada — 1.00%
- Novartis AG — 0.98%
- Astrazeneca Plc — 0.88%
- Nestle S.A. — 0.88%
- Shell Plc — 0.88%
- Siemens Aktiengesellschaft — 0.83%
FAQ
What is the difference between EFAX and IDEV?
Which is cheaper, EFAX or IDEV?
Should I own both EFAX and IDEV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.